Repository logo
 

EP-2298: Hypoxia inducible factor 1α confers androgen independence in prostate cancer

Published version
Peer-reviewed

Repository URI

https://www.repository.cam.ac.uk/handle/1810/290648

Repository DOI

https://doi.org/10.17863/CAM.37855
Thumbnail Image

Files

Published version (575.01 KB)

Type

Conference Object

Change log

Authors

Warren, Anne  ORCID logo  https://orcid.org/0000-0002-1170-7867

Abstract

Androgen receptor (AR) and hypoxia inducible factor 1a (HIF1a) are transcription factors that promote prostate cancer progression and radioresistance. This study investigated the relationship between the AR and HIF1a signaling pathways.

Description

Keywords

5105 Medical and Biological Physics, 32 Biomedical and Clinical Sciences, 3202 Clinical Sciences, 51 Physical Sciences, 3211 Oncology and Carcinogenesis

Journal Title

Radiotherapy and Oncology

Conference Name

ESTRO 37, Barcelona

Journal ISSN

0167-8140
1879-0887

Volume Title

127

Publisher

Elsevier

Publisher DOI

https://doi.org/10.1016/s0167-8140(18)32607-0

Rights and licensing

Attribution-NonCommercial-NoDerivatives 4.0 International
Except where otherwised noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 International
Sponsorship
Wellcome Trust (096956/Z/11/Z)
Department of Health (via National Institute for Health Research (NIHR)) (NF-SI-0514-10122)

Collections

University of Cambridge Research Outputs (Articles and Conferences)